Literature DB >> 7648706

T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis.

R Giscombe1, J Grunewald, S Nityanand, A K Lefvert.   

Abstract

Wegener's granulomatosis (WG) and polyarteritis nodosa (PAN) are systemic necrotizing vasculitides of unknown etiology. These disorders run a fatal course if untreated. T lymphocytes are implicated in the pathogenesis of WG, since they have been found to infiltrate affected organs, and sIL-2R correlates with disease activity. To elucidate further the role of T cells in necrotizing vasculitis, we have used a panel of 12 TCR V-specific MoAbs to investigate the number of cells expressing certain V alpha and V beta gene segments in the CD4+ and CD8+ subsets of altogether 11 patients with WG or PAN. In the group of patients, we found abnormal expansions of T cells using particular TCR V alpha or V beta gene products. These T cell expansions were more numerous, of a dramatically higher magnitude, and frequently more often found in the CD4 subset, compared with T cell expansions identified in healthy individuals. In long-term studies of the T cell expansions for up to 18 months, a heterogeneous pattern was revealed, with no obvious correlation to clinical features such as disease activity or treatment. Studies of TCR V gene usage in this group of patients may help in understanding the pathogenesis of necrotizing vasculitis, and in the identification of unknown antigens, and may open the possibility to a highly selective immunotherapy by targeting disease-mediating T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648706      PMCID: PMC1553259          DOI: 10.1111/j.1365-2249.1995.tb08341.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis).

Authors:  E W WALTON
Journal:  Br Med J       Date:  1958-08-02

2.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Authors:  R Y Leavitt; A S Fauci; D A Bloch; B A Michel; G G Hunder; W P Arend; L H Calabrese; J F Fries; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  Antibodies to components of neutrophil cytoplasm: a new diagnostic tool in patients with Wegener's granulomatosis and systemic vasculitis.

Authors:  K J Parlevliet; S C Henzen-Logmans; P L Oe; W Bronsveld; A J Balm; A J Donker
Journal:  Q J Med       Date:  1988-01

4.  The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms.

Authors:  F J van der Woude; L A van Es; M R Daha
Journal:  Neth J Med       Date:  1990-04       Impact factor: 1.422

5.  Association between polyarteritis and Australia antigen.

Authors:  D J Gocke; K Hsu; C Morgan; S Bombardieri; M Lockshin; C L Christian
Journal:  Lancet       Date:  1970-12-05       Impact factor: 79.321

6.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

7.  Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis.

Authors:  D R Moller; K Konishi; M Kirby; B Balbi; R G Crystal
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

8.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention.

Authors:  H Acha-Orbea; D J Mitchell; L Timmermann; D C Wraith; G S Tausch; M K Waldor; S S Zamvil; H O McDevitt; L Steinman
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

9.  The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa.

Authors:  R W Lightfoot; B A Michel; D A Bloch; G G Hunder; N J Zvaifler; D J McShane; W P Arend; L H Calabrese; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

10.  Selective expansion of T cells expressing V beta 2 in toxic shock syndrome.

Authors:  Y Choi; J A Lafferty; J R Clements; J K Todd; E W Gelfand; J Kappler; P Marrack; B L Kotzin
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Pathogenesis and treatment of ANCA-associated systemic vasculitis.

Authors:  A D Salama
Journal:  J R Soc Med       Date:  1999-09       Impact factor: 5.344

Review 2.  Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations.

Authors:  Laura B Hughes; S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 3.  Cellular aspects of vasculitis--T cell-mediated aspects.

Authors:  M E Griffith; C D Pusey
Journal:  Springer Semin Immunopathol       Date:  2001

Review 4.  Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  P Lamprecht
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

5.  Analysis of T-cell receptor usage in myeloperoxidase--antineutrophil cytoplasmic antibody-associated renal vasculitis.

Authors:  Kouichi Hirayama; Takashi Ishizu; Homare Shimohata; Yasunori Miyamoto; Tomoko Kakita; Miho Nagai; Yujiro Ogawa; Shogo Fujita; Aki Hirayama; Kunihiro Yamagata; Masaki Kobayashi; Akio Koyama
Journal:  Clin Exp Nephrol       Date:  2009-10-07       Impact factor: 2.801

6.  Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations.

Authors:  B Y Xu; R Giscombe; A Söderlund; M Troye-Blomberg; R Pirskanen; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

7.  Oligoclonal T cell expansions in patients with Behçet's disease.

Authors:  H Direskeneli; E Eksioglu-Demiralp; A Kibaroglu; S Yavuz; T Ergun; T Akoglu
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

8.  Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis.

Authors:  E R Popa; C A Stegeman; N A Bos; C G M Kallenberg; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

9.  Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity.

Authors:  R Giscombe; S Nityanand; N Lewin; J Grunewald; A K Lefvert
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

10.  An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.

Authors:  C Schaufelberger; R Andersson; E Nordborg; G K Hansson; C Nordborg; J Wahlström
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.